Skip to content
  • Tuesday, 27 October 2026
  • 6:32 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Merck and Moderna’s cancer vaccine is customized for each patient’s tumor
Laboratory Automation & Robotics

Merck and Moderna’s cancer vaccine is customized for each patient’s tumor

Lana Keisha Oct 27, 2026 0

The landscape of oncology is currently undergoing a paradigm shift as pharmaceutical giants Merck & Co. and biotechnology innovator Moderna…

Read More
Laboratory Automation & Robotics

Merck and Moderna’s cancer vaccine is customized for each patient’s tumor

Lana Keisha Oct 13, 2026 0

The landscape of oncology is undergoing a seismic shift as pharmaceutical giants Merck & Co. and Moderna reach a pivotal…

Read More
Laboratory Automation & Robotics

Merck and Moderna’s cancer vaccine is customized for each patient’s tumor

Lana Keisha Oct 4, 2026 0

The landscape of oncology is currently undergoing a paradigm shift as pharmaceutical giants Merck & Co. and Moderna advance their…

Read More
Pharmaceutical R&D

Daiichi Sankyo and Merck Voluntarily Withdraw US Application for Lung Cancer Drug Ifinatamab Deruxtecan Following FDA Discussions

Teuku Ryan Sep 29, 2026 0

Pharmaceutical giants Daiichi Sankyo and Merck & Co., known globally as MSD, have officially announced the voluntary withdrawal of their…

Read More
Laboratory Automation & Robotics

Merck and Moderna’s cancer vaccine is customized for each patient’s tumor

Lana Keisha Sep 27, 2026 0

The landscape of oncology is currently undergoing a paradigm shift as pharmaceutical giants Merck & Co. and Moderna move toward…

Read More
Laboratory Automation & Robotics

Merck and Moderna’s cancer vaccine is customized for each patient’s tumor

Lana Keisha Sep 20, 2026 0

The landscape of oncology is currently undergoing a paradigm shift as pharmaceutical giants Merck & Co. and Moderna transition from…

Read More
Laboratory Automation & Robotics

Merck and Moderna’s cancer vaccine is customized for each patient’s tumor

Lana Keisha Sep 12, 2026 0

The landscape of oncology is undergoing a fundamental transformation as pharmaceutical giants Merck & Co. and Moderna move toward the…

Read More
Laboratory Automation & Robotics

Weekly Gilead and Merck oral HIV regimen maintains suppression in two phase 3 trials

Lana Keisha Jul 21, 2026 0

Recent findings presented at the 26th International AIDS Conference have underscored a significant advancement in HIV treatment, with an investigational…

Read More
Pharmaceutical R&D

Merck & Co. Acquires Terns Pharmaceuticals, Bolstering Chronic Myeloid Leukemia Pipeline with FDA Breakthrough Designation for TERN-701

Teuku Ryan May 6, 2026 0

Merck & Co. (MSD) has successfully completed its acquisition of Terns Pharmaceuticals, a strategic move that significantly enhances MSD’s portfolio…

Read More
Pharmaceutical R&D

Merck KGaA and Remepy Forge Groundbreaking Partnership to Pioneer "Hybrid Drugs" for Rare Cancers

Teuku Ryan Apr 28, 2026 0

In a move that signals a significant shift in pharmaceutical innovation, Merck KGaA has announced a strategic collaboration with Remepy,…

Read More

Posts pagination

1 2
Turning the Tables on Termites: How Biological Vulnerabilities are Reshaping Structural Pest ControlRevolutionary Human-Cell Bone Marrow Model Promises to Transform Blood Research and Reduce Animal TestingJohns Hopkins Researchers Discover How Gene Fusion Droplets Drive Rare Kidney Cancer ProgressionThe Roadmap to Becoming a Computer Vision Engineer in 2026: Mastering Spatial Computing, Foundation Models, and Edge Deployment
The Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactEliquis Loss of Exclusivity: A Pharmaceutical Patent Cliff of Historic ProportionsMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric Growth
Merck and Moderna’s cancer vaccine is customized for each patient’s tumorAn Unbiased Look at Google Gemini Omni: Features, Costs, and Market ComparisonESMO 2026: Sacituzumab Tirumotecan Sets New Survival Benchmark in Recurrent Endometrial CancerLight-Driven Magnetism Breakthrough Promises Ultrafast, High-Density Digital Data Storage
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Merck and Moderna’s cancer vaccine is customized for each patient’s tumor
Lana Keisha Oct 27, 2026
Data Science & Bioinformatics
An Unbiased Look at Google Gemini Omni: Features, Costs, and Market Comparison
Evan Lee Salim Oct 27, 2026
Pharmaceutical R&D
ESMO 2026: Sacituzumab Tirumotecan Sets New Survival Benchmark in Recurrent Endometrial Cancer
Teuku Ryan Oct 27, 2026
Advanced Materials Science
Light-Driven Magnetism Breakthrough Promises Ultrafast, High-Density Digital Data Storage
Nila Kartika Wati Oct 27, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ